Finance

Lists
4552:TYO
JCR Pharmaceuticals Co Ltd
493,00 JPY
+0,82%
(+4,00) 1D
6 აგვ, 15:30:00 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4552...
Open
489 JPY
High
500 JPY
Low
486 JPY
Mkt. cap
63,94 მლრდ.
Avg. vol.
640,44 ათ.
Volume
537,20 ათ.
Dividend
4,06%
Quarterly dividend
5 JPY
Ex-dividend date
29 სექ. 2026
P/E ratio
73,53
52-wk high
824 JPY
52-wk low
444 JPY
EPS
7 JPY
Shares outstanding
30,79 მლნ.
No. of employees
985
Open
489 JPY
High
500 JPY
Low
486 JPY
Mkt. cap
63,94 მლრდ.
Avg. vol.
640,44 ათ.
Volume
537,20 ათ.
Dividend
4,06%
Quarterly dividend
5 JPY
Ex-dividend date
29 სექ. 2026
P/E ratio
73,53
52-wk high
824 JPY
52-wk low
444 JPY
EPS
7 JPY
Shares outstanding
30,79 მლნ.
No. of employees
985
News stories
From sources across the web
CoinDesk
CoinDesk
·
2 საათის წინ
Bitcoin is stuck as Wall Street prints crypto's $2T market cap. Here's why.
Benzinga
Benzinga
·
5 წუთის წინ
Stock Market: Will S&P 500 Open Up or Down Today?
WSJ
WSJ
·
11 საათის წინ
Strong Earnings Power Dow to Another Record
Investor's Business Daily
Investor's Business Daily
·
5 საათის წინ
Futures Mixed As Memory Giants Lead Losers Late
About JCR Pharmaceuticals Co Ltd
CEO-
Employees985
Founded13 სექ. 1975
Headquarters-
SectorPharmaceutical industry
Websitejcrpharm.co.jp
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
12,79 მლრდ.
8,99 მლრდ.
9,97 მლრდ.
9,70 მლრდ.
Cost of goods sold
1,97 მლრდ.
2,39 მლრდ.
3,42 მლრდ.
2,25 მლრდ.
Cost of revenue
1,97 მლრდ.
2,39 მლრდ.
3,42 მლრდ.
2,25 მლრდ.
Research and development expenses
-
-
16,76 მლრდ.
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7,84 მლრდ.
8,50 მლრდ.
-10,29 მლრდ.
9,55 მლრდ.
Operating expense
7,88 მლრდ.
8,54 მლრდ.
6,48 მლრდ.
9,55 მლრდ.
Total operating expenses
9,85 მლრდ.
10,93 მლრდ.
9,90 მლრდ.
11,80 მლრდ.
Operating income
2,95 მლრდ.
-1,94 მლრდ.
66,00 მლნ.
-2,10 მლრდ.
Other non operating income
32,00 მლნ.
49,00 მლნ.
-65,00 მლნ.
135,00 მლნ.
EBT including unusual items
3,29 მლრდ.
281,00 მლნ.
402,00 მლნ.
-2,08 მლრდ.
EBT excluding unusual items
3,07 მლრდ.
-1,64 მლრდ.
28,00 მლნ.
-2,08 მლრდ.
Income tax expense
1,01 მლრდ.
157,00 მლნ.
27,00 მლნ.
-166,00 მლნ.
Effective tax rate
30,79%
55,87%
6,72%
7,97%
Other operating expenses
-
-
-
-
Net income
2,26 მლრდ.
69,00 მლნ.
399,00 მლნ.
-1,91 მლრდ.
Net profit margin
17,63%
0,77%
4,00%
-19,66%
Earnings per share
-
-
-
-
Interest and investment income
30,00 მლნ.
33,00 მლნ.
27,00 მლნ.
23,00 მლნ.
Interest expense
-78,00 მლნ.
-151,00 მლნ.
-90,00 მლნ.
-157,00 მლნ.
Net interest expenses
-48,00 მლნ.
-118,00 მლნ.
-63,00 მლნ.
-134,00 მლნ.
Depreciation and amortization charges
39,00 მლნ.
36,00 მლნ.
12,00 მლნ.
-
EBITDA
3,68 მლრდ.
-1,09 მლრდ.
705,25 მლნ.
-1,46 მლრდ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები